Variant report

Variant	nsv1066225
Chromosome Location	chr19:41968797-42007875
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:293)
CpG islands
(count:61)
Chromatin interactive
region (count:5)
LncRNA
region (count:27)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:293 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41985894-41986022	K562	blood:	n/a	n/a
2	ARID3A	chr19:41969568-41969577	HepG2	liver:	n/a	n/a
3	ATF1	chr19:41985515-41985820	K562	blood:	n/a	n/a
4	ATF3	chr19:42007044-42007229	K562	blood:	n/a	n/a
5	BACH1	chr19:41985825-41985834	K562	blood:	n/a	n/a
6	BATF	chr19:41969389-41969829	GM12878	blood:	n/a	n/a
7	BATF	chr19:41969506-41969785	GM12878	blood:	n/a	n/a
8	BATF	chr19:42007315-42007464	GM12878	blood:	n/a	n/a
9	BCL11A	chr19:41969539-41969773	GM12878	blood:	n/a	n/a
10	BCL11A	chr19:41969464-41969856	GM12878	blood:	n/a	n/a
11	BHLHE40	chr19:41985631-41985823	K562	blood:	n/a	n/a
12	BHLHE40	chr19:41969578-41969860	GM12878	blood:	n/a	n/a
13	BHLHE40	chr19:41986254-41986585	K562	blood:	n/a	n/a
14	BHLHE40	chr19:42007430-42007554	K562	blood:	n/a	n/a
15	CBX3	chr19:41985547-41986099	K562	blood:	n/a	n/a
16	CBX3	chr19:42007176-42007860	HCT-116	colon:	n/a	n/a
17	CBX3	chr19:41968455-41968815	K562	blood:	n/a	n/a
18	CBX3	chr19:41968460-41968804	K562	blood:	n/a	n/a
19	CEBPB	chr19:41992290-41992562	HepG2	liver:	n/a	n/a
20	CEBPB	chr19:41992986-41993092	IMR90	lung:	n/a	chr19:41993068-41993079
21	CEBPB	chr19:41992919-41993068	HepG2	liver:	n/a	n/a
22	CEBPB	chr19:41992890-41993261	HepG2	liver:	n/a	chr19:41993068-41993079
23	CEBPB	chr19:41969394-41969671	K562	blood:	n/a	chr19:41969517-41969528
24	CEBPB	chr19:41969468-41969606	HepG2	liver:	n/a	chr19:41969517-41969528
25	CEBPB	chr19:41969387-41969721	HepG2	liver:	n/a	chr19:41969517-41969528
26	CEBPB	chr19:41969353-41969755	HepG2	liver:	n/a	chr19:41969517-41969528
27	CEBPB	chr19:41969409-41969618	A549	lung:	n/a	chr19:41969517-41969528
28	CEBPB	chr19:41969487-41969587	IMR90	lung:	n/a	chr19:41969517-41969528
29	CEBPB	chr19:41969489-41969670	Hela-S3	cervix:	n/a	chr19:41969517-41969528
30	CEBPB	chr19:41969385-41969602	K562	blood:	n/a	chr19:41969517-41969528
31	CEBPB	chr19:41992465-41992478	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr19:41992260-41992553	A549	lung:	n/a	n/a
33	CEBPB	chr19:41992947-41993198	A549	lung:	n/a	chr19:41993068-41993079
34	CTCF	chr19:41969932-41970017	MCF-7	breast:	n/a	n/a
35	CTCF	chr19:41969842-41970107	A549	lung:	n/a	n/a
36	CTCF	chr19:41969863-41969952	Spleen_OC	spleen:	n/a	n/a
37	CTCF	chr19:41969863-41970051	GM12878	blood:	n/a	n/a
38	CTCF	chr19:41969868-41970195	GM19238	blood:	n/a	n/a
39	CTCF	chr19:41970175-41970202	GM19239	blood:	n/a	n/a
40	CTCF	chr19:41969855-41970092	GM19240	blood:	n/a	n/a
41	CTCF	chr19:41969318-41969332	GM12892	blood:	n/a	n/a
42	CTCF	chr19:41992387-41992397	Kidney_OC	kidney:	n/a	n/a
43	CTCF	chr19:41969900-41970047	A549	lung:	n/a	n/a
44	CTCF	chr19:41969882-41970024	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr19:41969867-41970050	Gliobla	brain:	n/a	n/a
46	CTCF	chr19:41969888-41970071	GM12891	blood:	n/a	n/a
47	CTCF	chr19:41984280-41984430	HEK293	kidney:	n/a	n/a
48	CTCF	chr19:41984420-41984570	A549	lung:	n/a	n/a
49	CTCF	chr19:41969929-41970001	MCF-7	breast:	n/a	n/a
50	CTCF	chr19:41984200-41984350	A549	lung:	n/a	chr19:41984245-41984254 chr19:41984245-41984258

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42007378-42007428	RPTEC	kidney:	n/a
2	chr19:42007378-42007428	SKMC	muscle:	n/a
3	chr19:42007378-42007428	HRPEpiC	eye:	n/a
4	chr19:42007378-42007428	HUVEC	blood vessel:	n/a
5	chr19:42007378-42007428	CMK	blood:	n/a
6	chr19:42007378-42007428	ECC-1	luminal epithelium:	n/a
7	chr19:42007378-42007428	AG04449	skin:	fetal
8	chr19:42007378-42007428	GM12891	blood:	n/a
9	chr19:42007378-42007428	A549	lung:	n/a
10	chr19:42007378-42007428	K562	blood:	n/a
11	chr19:42007378-42007428	HL-60	blood:	n/a
12	chr19:42007378-42007428	SK-N-SH	brain:	n/a
13	chr19:42007378-42007428	AG09309	skin:	n/a
14	chr19:42007378-42007428	GM19239	blood:	n/a
15	chr19:42007378-42007428	PFSK-1	brain:	n/a
16	chr19:42007378-42007428	ProgFib	skin:	n/a
17	chr19:42007378-42007428	ovcar-3	ovarian:	n/a
18	chr19:42007378-42007428	GM06990	blood:	n/a
19	chr19:42007378-42007428	Hepatocyte	liver:	n/a
20	chr19:42007378-42007428	MCF-7	breast:	n/a
21	chr19:42007378-42007428	HEEpiC	esophagus:	n/a
22	chr19:42007378-42007428	HepG2	liver:	n/a
23	chr19:42007378-42007428	Jurkat	blood:	n/a
24	chr19:42007378-42007428	AG10803	skin:	n/a
25	chr19:42007378-42007428	AG04450	lung:	fetal
26	chr19:42007378-42007428	AG09319	gingival:	n/a
27	chr19:42007378-42007428	NHDF-neo	bronchial:	n/a
28	chr19:42007378-42007428	HCF	heart:	n/a
29	chr19:42007378-42007428	NB4	blood:	n/a
30	chr19:42007378-42007428	HMEC	breast:	n/a
31	chr19:42007378-42007428	SK-N-SH_RA	brain:	n/a
32	chr19:42007378-42007428	Caco-2	colon:	n/a
33	chr19:42007378-42007428	Hela-S3	cervix:	n/a
34	chr19:42007378-42007428	MCF10A-Er-Src	breast:	n/a
35	chr19:42007378-42007428	SAEC	small airway:	n/a
36	chr19:42007378-42007428	NHBE	bronchial:	n/a
37	chr19:42007378-42007428	T-47D	breast:	n/a
38	chr19:42007378-42007428	H1-hESC	embryonic stem cell:	embryo
39	chr19:42007378-42007428	SK-N-MC	brain:	n/a
40	chr19:42007378-42007428	HCPEpiC	choroid plexus:	n/a
41	chr19:42007378-42007428	GM12892	blood:	n/a
42	chr19:42007378-42007428	PrEC	prostate:	n/a
43	chr19:42007378-42007428	U87	brain:	n/a
44	chr19:42007378-42007428	AoSMC	blood vessel:	n/a
45	chr19:42007378-42007428	IMR90	lung:	fetal
46	chr19:42007378-42007428	HAEpiC	amniotic membrane:	n/a
47	chr19:42007378-42007428	HRCEpiC	kidney:	n/a
48	chr19:42007378-42007428	HNPCEpiC	eye:	n/a
49	chr19:42007378-42007428	NH-A	brain:	n/a
50	chr19:42007378-42007428	HEK293	kidney:	embryo

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41944061..41946977-chr19:42000429..42002001,2	K562	blood:
2	chr19:41970790..41973417-chr19:42039173..42040939,2	K562	blood:
3	chr19:41945911..41947481-chr19:41988789..41990689,2	K562	blood:
4	chr19:41944280..41946189-chr19:42004239..42006678,2	K562	blood:
5	chr19:41979781..41981328-chr19:41984407..41987088,2	K562	blood:

(count:27 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ATP5SL-1	chr19:41980371-41980444	ENSG00000267107.2
2	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066458
3	lnc-ATP5SL-1	chr19:42006494-42006554	NONHSAT066453
4	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
5	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
6	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066451
7	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000267107.2
8	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066457
9	lnc-ATP5SL-1	chr19:41984989-41985051	ENSG00000267107.2
10	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066458
11	lnc-ATP5SL-1	chr19:42006494-42006545	NONHSAT066458
12	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
13	lnc-ATP5SL-1	chr19:41985040-41985192	NONHSAT066459
14	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
15	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066453
16	lnc-ATP5SL-1	chr19:42006494-42006539	ENSG00000267107.2
17	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000267107.2
18	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066451
19	lnc-ATP5SL-1	chr19:42006494-42006559	ENSG00000249527
20	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000267107.2
21	lnc-ATP5SL-1	chr19:42006494-42006540	NONHSAT066451
22	lnc-ATP5SL-1	chr19:42001210-42001335	ENSG00000267107.2
23	lnc-ATP5SL-1	chr19:42006494-42006538	NONHSAT066457
24	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
25	lnc-ATP5SL-1	chr19:42001210-42001338	NONHSAT066459
26	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000249527
27	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527

No data

Variant related genes	Relation type
ENSG00000267107	TF binding region
ENSG00000268034	TF binding region
ENSG00000267107	CpG island
ENSG00000268034	CpG island
ENSG00000105341	chromatin interactions
ENSG00000267107	chromatin interactions
SPTBN1	miRNA target sites
CHST11	miRNA target sites
TMED7	miRNA target sites
PRSS21	miRNA target sites
EZH2	miRNA target sites
CNN3	miRNA target sites

Extended variants
information (count: 1631 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:1631 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184142650	chr19:41968815-41968816	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs587773472	chr19:41968823-41968824	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs376145065	chr19:41968826-41968827	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs587733944	chr19:41968850-41968851	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs190650491	chr19:41968853-41968854	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs181771445	chr19:41968918-41968919	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs186192686	chr19:41968920-41968921	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs587603006	chr19:41969064-41969065	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs587663034	chr19:41969075-41969076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs190604164	chr19:41969079-41969080	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs587599791	chr19:41969110-41969111	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs587671478	chr19:41969190-41969191	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs587721964	chr19:41969191-41969192	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs150916230	chr19:41969216-41969217	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs2098107	chr19:41969273-41969274	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs587747497	chr19:41969277-41969278	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs139358706	chr19:41969291-41969292	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs56877735	chr19:41969292-41969293	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs114687182	chr19:41969307-41969308	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs147722112	chr19:41969323-41969324	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs587707374	chr19:41969346-41969347	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs587763048	chr19:41969350-41969351	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs181543659	chr19:41969354-41969355	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs186718495	chr19:41969357-41969358	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs372693269	chr19:41969375-41969376	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs376539647	chr19:41969391-41969392	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs191007544	chr19:41969417-41969418	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs376157734	chr19:41969436-41969437	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs140781099	chr19:41969457-41969458	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs117653620	chr19:41969528-41969529	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs587720503	chr19:41969555-41969556	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs370907161	chr19:41969559-41969560	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs182852934	chr19:41969560-41969561	Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372833276	chr19:41969622-41969623	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs10406791	chr19:41969678-41969679	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs587601880	chr19:41969686-41969687	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs587668174	chr19:41969705-41969706	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs187519591	chr19:41969706-41969707	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs145698519	chr19:41969708-41969709	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs148939319	chr19:41969790-41969791	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs587772975	chr19:41969814-41969815	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs587754172	chr19:41969837-41969838	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs377055751	chr19:41969857-41969858	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs12459980	chr19:41969858-41969859	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs587683155	chr19:41969866-41969867	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs73049161	chr19:41969867-41969868	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs111603372	chr19:41969870-41969871	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs114383587	chr19:41969881-41969882	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs587686122	chr19:41969885-41969886	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs191104638	chr19:41969890-41969891	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:218 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41968400-41970800	Enhancers	Primary B cells from peripheral blood	blood
2	chr19:41968400-41982200	Weak transcription	HUVEC	blood vessel
3	chr19:41968600-41969200	Enhancers	GM12878-XiMat	blood
4	chr19:41969000-41970600	Enhancers	Primary B cells from cord blood	blood
5	chr19:41969200-41969400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
6	chr19:41969200-41969400	Enhancers	Lung	lung
7	chr19:41969200-41969600	Flanking Active TSS	GM12878-XiMat	blood
8	chr19:41969200-41969600	Enhancers	HepG2	liver
9	chr19:41969200-41969800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
10	chr19:41969200-41970200	Enhancers	Primary monocytes fromperipheralblood	blood
11	chr19:41969400-41969600	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
12	chr19:41969400-41969600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
13	chr19:41969600-41969800	Enhancers	GM12878-XiMat	blood
14	chr19:41969800-41970000	Flanking Active TSS	GM12878-XiMat	blood
15	chr19:41969800-41970200	Enhancers	Monocytes-CD14+_RO01746	blood
16	chr19:41970000-41970200	Enhancers	Lung	lung
17	chr19:41970000-41970600	Enhancers	GM12878-XiMat	blood
18	chr19:41973000-41973600	Bivalent/Poised TSS	A549	lung
19	chr19:41976600-41976800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
20	chr19:41976600-41976800	Enhancers	Spleen	Spleen
21	chr19:41976800-41978800	Weak transcription	Spleen	Spleen
22	chr19:41978800-41979600	Enhancers	Spleen	Spleen
23	chr19:41979600-41982200	Weak transcription	Spleen	Spleen
24	chr19:41982200-41982400	Enhancers	Spleen	Spleen
25	chr19:41982200-41982800	Enhancers	GM12878-XiMat	blood
26	chr19:41982200-41983200	Enhancers	Primary B cells from peripheral blood	blood
27	chr19:41982200-41983400	Enhancers	HUVEC	blood vessel
28	chr19:41982400-41982800	Weak transcription	Spleen	Spleen
29	chr19:41982400-41983800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
30	chr19:41982800-41983000	Enhancers	Left Ventricle	heart
31	chr19:41982800-41983000	Enhancers	Right Atrium	heart
32	chr19:41982800-41983000	Enhancers	Spleen	Spleen
33	chr19:41982800-41983000	Flanking Active TSS	GM12878-XiMat	blood
34	chr19:41982800-41983600	Enhancers	Lung	lung
35	chr19:41983000-41983600	Genic enhancers	Left Ventricle	heart
36	chr19:41983000-41984000	Weak transcription	Right Atrium	heart
37	chr19:41983000-41986400	Weak transcription	Spleen	Spleen
38	chr19:41983400-41984000	Enhancers	Fetal Muscle Leg	muscle
39	chr19:41983400-41986400	Flanking Active TSS	HUVEC	blood vessel
40	chr19:41983600-41984200	Enhancers	Left Ventricle	heart
41	chr19:41983600-41985200	Active TSS	Lung	lung
42	chr19:41983800-41984600	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
43	chr19:41983800-41985000	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
44	chr19:41984000-41984200	Bivalent Enhancer	Adipose Nuclei	Adipose
45	chr19:41984000-41984200	Weak transcription	Fetal Muscle Leg	muscle
46	chr19:41984000-41984200	Enhancers	Right Atrium	heart
47	chr19:41984200-41984400	Bivalent/Poised TSS	Fetal Stomach	stomach
48	chr19:41984200-41984400	Flanking Active TSS	Left Ventricle	heart
49	chr19:41984200-41984800	Bivalent/Poised TSS	Right Ventricle	heart
50	chr19:41984200-41985000	Active TSS	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links